Header with NDRS and NHS ENGLAND logos. Decorative only.

ODN Report: National Overview

Reporting period: July 2024 to June 2025

Introduction and Definitions

Introduction

The Operational Delivery Network (ODN) reports are produced every 6 months by the National Disease Registration Service. It is a summary of activity reports and metrics available on CancerStats2. This report uses data from the CAS snapshot CAS2510 (and includes RTDS activity up to June 2025). Further details on each of the reports can be found on CancerStats2.

ODNs are a delivery network for radiotherapy services. They were established by the Adult External Beam Radiotherapy Services Service Specification in 2019. Each Network is tasked with providing radiotherapy system leadership and the delivery of NHS England’s vision and ambitions for the modernisation of radiotherapy service.

Quality Metrics Definitions

The report includes summaries of the Specialised Services Quality Dashboards (SSQDs) metrics, referred to in this report as “Quality dashboard”. The purpose of collecting SSQD data is to monitor the quality of these specialised services, helping providers and commissioning teams identify areas for improvement to ensure better patient outcomes and fair, safe care. CS2 provides the metrics by Trust of delivery, whereas this report focuses on the ODN regions, aggregating the trusts within it.

The definitions for the quality metrics are as follows.

RAD12A: Percentage of radical episodes (excluding non-melanoma skin cancer) where the difference between decision to treat date and treatment start date is greater than 31 days.
Description: The number of radical episodes (excluding non-melanoma skin cancer episodes) where the difference between the decision to treat date and the treatment start date is over 31 days, by the number of all radical episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-D48 excluding C44. Earliest clinically appropriate date is used where the episode is missing the decision to treat date. If both dates are available, the most recent (greatest) date from either the decision to treat date and earliest clinically appropriate date is used. External beam radiotherapy only.

RAD12B: Percentage of palliative episodes (excluding non-melanoma skin cancer) where the difference between the decision to treat date and treatment start date is greater than 31 days.
Description: The number of palliative episodes (excluding non-melanoma skin cancer episodes) where the difference between the decision to treat and the treatment start date is greater than 31 days, by the number of all palliative episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-D48 excluding C44. Earliest clinically appropriate date is used where the episode is missing the decision to treat date. If both dates are available, the most recent (greatest) date from either the decision to treat date and earliest clinically appropriate date is used. External beam radiotherapy only.

RAD13A: Percentage of radical lung episodes.
Description: The number of radical lung episodes, by the number of all lung episodes starting treatment in the reporting period.
Exceptions and assumptions: Includes all lung treatments, including SABR treatment. ICD10 codes C33-C34 only are included. External beam radiotherapy only.

RAD13B: Percentage of radical lung SABR episodes.
Description: The number of radical lung SABR episodes, divided by the number of all radical lung episodes starting treatment in the reporting period.
Exceptions and assumptions: Includes only SABR treatments. ICD10 codes C33-C34 only are included. External beam radiotherapy only.

RAD13C: Percentage of radical head and neck episodes.
Description: The number of radical head and neck episodes, divided by the number of all head and neck episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-C14 and C30-C32 only are included. External beam radiotherapy only.

RAD13D: Percentage of radical cervical episodes.
Description: The number of radical cervical episodes, divided by the number of all cervical episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 code C53 only is included. External beam radiotherapy only.

RAD14: Percentage of radical IMRT episodes.
Description: The number of radical IMRT episodes (including any SABR episodes), divided by the number of all radical episodes starting treatment in the reporting period.
Exceptions and assumptions: Numerator radical IMRT episodes: Excludes ICD10 codes C50, D05 and C44. Denominator all radical episodes: Excludes ICD10 code C44 only. External beam radiotherapy only.

RAD15A: Percentage of radical lung episodes treated using image guidance.
Description: The number of radical lung IMRT episodes (including any SABR episodes), divided by the number of all radical lung episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 code C33 - C34 only are included. External beam radiotherapy only. Radical episodes only.

RAD15B: Percentage of radical prostate episodes treated using image guidance.
Description: The number of radical prostate IMRT episodes (including any SABR episodes), divided by the number of all radical prostate episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 code C61 only is included. External beam radiotherapy only. Radical episodes only.

RAD15C: Percentage of radical head and neck episodes treated using image guidance.
Description: The number of radical head and neck IMRT episodes (including any SABR episodes), divided by the number of all radical head and neck episodes starting treatment in the reporting period.
Exceptions and assumptions: ICD10 codes C00-C14, C30-C32 only are included. External beam radiotherapy only. Radical episodes only.

RAD16: Average number of days between date of referral to a radiotherapy department to the treatment start date for Category 1 episodes.
Description: Sum of the number of days waited from decision to treat date to the treatment start date, divided by the number of episodes starting treatment in the reporting period.
Exceptions and assumptions: Earliest clinically appropriate date is used where episode is missing decision to treat date. If both dates are available, the most recent (greatest) date from either the decision to treat date and earliest clinically appropriate date is used. Radical episodes only. External beam radiotherapy only. Category 1 episodes only, including: Site (ICD10 codes) Head and Neck (C00-C06, C09-C14); Cervix, Vagina and Vulva (C51-C53); Anus (C21); Lung (C30-C36, C39); Oesophagus (C15)

RAD17: Percentage of breast episodes treated with less than or equal to 15 prescribed fractions.
Description: The number of breast episodes where the first prescription in the episode has 15 or less prescribed fractions, divided by the number of all breast episodes starting treatment in the reporting period.
Exceptions and assumptions: Excludes any episodes that are non-anatomically specific to the primary treatment region or metastasis. ICD10 codes C50 or D05 only are included. External beam radiotherapy only. Excludes electron beam treatment. Excludes palliative treatment.

RAD18: Percentage of metastatic bone episodes treated in a single attendance.
Description: The number of metastatic bone episodes treated in a single attendance, divided by the number of all metastatic bone episodes starting treatment in the reporting period.
Exceptions and assumptions: OPCS codes Z63-Z66, Z68-Z80 or Z84-Z87 only are included. Spinal cord compression with the expected OPCS codes of Z06 and Z07 are excluded. External beam radiotherapy only. Metastatic treatment region only included.

RAD19: Percentage of prostate episodes treated in 5, 19 or 20 attendances.
Description: Number of prostate episodes treated in 5, 19 or 20 attendances, divided by the number of prostate episodes treated in 5, 19, 20 or more attendances in the reporting period.
Exceptions and assumptions: ICD10 code C61 only included. External beam radiotherapy only. Excludes prophylactic and non-anatomically specific to the primary.

RAD20: Departmental average number of attendances per linac
Description: The total number of attendances divided by the total number of LINACs.
Exceptions and assumptions: Linac attendances only.

Events Dashboard Definitions

The events by provider (mapped up to ODN) are defined as a count of the number of events by provider where a patient was treated with radiotherapy. This count includes all patient activity associated with the provider, regardless of postcode (including overseas, null, invalid, etc.).

Episode count is a count of episodes starting in that month.

Attendance count is a count of appointments in that month.

Dose and Fractionation Definitions

Patients - the report includes all adult patients aged 18+.

RTDS activity is defined as a unique count of treatment episodes. A treatment episode is defined as a continuous period of care for radiotherapy including all preparation, planning and delivery of radiotherapy.

Dose and fractionation schedules have been compared to the guidance provided by the Royal College of Radiologists for radiotherapy treatments occurring during Covid 19, in addition to the standard radiotherapy dose fractionation guidance produced by the RCR. This guidance can be found on the RCR website.

Fractionation Categories:

Low Fractionation - less than 2Gy per fraction
Standard Fractionation - 2.0Gy - 2.49Gy per fraction
Mild-Moderate hypofractionation - 2.5Gy - 4.99Gy
Ultra-High hypofractionation - 5Gy or greater

Episode count is a count of episodes starting in that month.

About the NDRS

The National Disease Registration Service (NDRS) is part of NHS England (NHSE). Its purpose is to collect, curate, quality-assure and analyse on patients with cancer, congenital anomalies, and rare diseases. It provides robust surveillance to monitor and detect changes in health and disease in the population. NDRS is a vital resource that helps researchers, healthcare professionals and policy makers make decisions about NHS services and the treatments people receive.

The NDRS includes:

the National Cancer Registration and Analysis Service (NCRAS) and
the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS)

Healthcare professionals, researchers and policy makers use data to better understand population health and disease. The data is provided by patients and collected by the NHS as part of their care and support. The NDRS uses the data to help:

understand cancer, rare diseases, and congenital anomalies
improve diagnosis
plan NHS services
improve treatment
evaluate policy
improve genetic counselling

For queries relating to this document, please contact NDRS.datasets@nhs.net

Contacts and Resources at NDRS

The National Disease Registration Service (NDRS) are making every effort to support each NHS Trust in achieving the highest levels of data quality in their RTDS submission. To support this aim, the following resources are available:

Your NDRS Data Liaison Manager
Your Data Liaison Manager can provide extensive support to improve the quality of data submitted to the National Disease Registration Service. Please contact the RTDS Helpdesk: rtds.helpdesk@nhs.net for further details.

NDRS Data Hub and Website
A single point of access for all NDRS related information including cancer data collection, datasets, supporting tools, training materials and guidance documents: NDRS Data Hub: NDRS Data Hub.

CancerStats2
CancerStats2 is a secure reporting platform that is only available to organisations with a HSCN connection. The platform hosts a variety of RTDS dashboards, including the radiotherapy quality metrics dashboard, the dose and fractionation dashboard and regularly updated operational data. In addition to RTDS data, the platform features dashboards reporting for cancer incidence and mortality, molecular and genetics and systemic anti-cancer therapy. CancerStats2 platform enables key stakeholders to generate reports using NDRS data on a self-service basis. If you do not currently have access please contact the RTDS Helpdesk (rtds.helpdesk@nhs.net).

Data sources
The dashboards referenced here can be found on CancerStats2 below:

A HSCN connection and CancerStats2 account are required to access the dashboards.

Patient acknowledgement This work uses data that has been provided by patients and collected by the NHS as part of their care and support. The data is collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of NHS England.

Data Quality and Caveats

Providers

From January 2023, Salford Royal / Northern Care Alliance (trust code: RM3) is included with the Christie NHS Foundation Trust (trust code: RBV) data for all metrics in this report.

North Cumbria Integrated Care NHS Foundation Trust (RNN) merged with The Newcastle Upon Tyne NHS Foundation Trust (RTD) from April 2023. Data reported for RNN in the period January 2023 to June 2023 will therefore not represent a full six-month period, with all data reported under RTD from this point onwards.

The Royal Marsden NHS Foundation Trust have approximately 10% of their RTDS data missing between April 2023 and December 2023. The Royal Marsden typically account for 3-4% of all radiotherapy episodes in England.

Some providers have missing/low data in the period covered by this report due to the transition to V6.

Decision to treat date

The RTDS data item decision to treat date is used in the following metrics as a start point for time to treatment. In some instances, particularly in data for The Christie NHS Foundation Trust (RBV) and University Hospitals Coventry and Warwickshire (RKB), an incorrect decision to treat date is assigned to an episode because the patient has had a previous primary tumour. In the period January 2020 to June 2024 this affects less than 1% of tumours.

Using the report

The report contents can be found in the sidebar to the left of the main panel. Click on the headings to see the different sections available and navigate to that part of the report.

For more information about the data, hover over the data points on the graph.

To zoom in or out of the chart, click the plus or minus symbols at the top right-hand side or draw a box within the chart to zoom in on that area.

To move around the chart, click on the cross (‘Pan’) symbol at the top right-hand side. To reset the chart, click on the house symbol at the top right-hand side.

To focus on specific elements on the chart:

Click on the item in the legend to remove a line or set of data points
Double click on the item in the legend to select a line or set of data points.

In some cases, numbers for categories may be too small to be visible on the chart or via the tooltip, although they are included in the totals and on the legend. To see these, double click on the category in the legend as above.

Save the plot as a PNG file by clicking on the camera symbol at the top right-hand side.

Episodes

Episodes table

Radiotherapy Network	Total	07/2024	08/2024	09/2024	10/2024	11/2024	12/2024	01/2025	02/2025	03/2025	04/2025	05/2025	06/2025
Total	148,316	13,874	12,385	12,682	13,774	12,613	11,710	13,464	12,180	12,577	11,466	10,861	10,730
East Midlands	9,839	929	833	889	915	908	784	932	885	694	720	710	640
East of England	12,424	1,164	1,105	1,068	1,175	1,075	992	1,159	1,066	1,132	828	819	841
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	21,127	1,937	1,803	1,765	1,833	1,844	1,658	1,849	1,645	1,745	1,751	1,636	1,661
North Central and North East London	13,459	1,345	1,114	1,204	1,303	1,177	1,028	1,210	1,072	1,171	1,141	1,118	576
North East and Cumbria	10,235	860	802	799	857	803	818	891	856	945	859	815	930
Peninsula, Somerset, Avon and Gloucestershire	15,320	1,382	1,221	1,244	1,391	1,190	1,208	1,370	1,245	1,220	1,315	1,237	1,297
South East London, Kent and Medway	8,893	806	734	704	799	757	700	794	687	747	695	705	765
Thames Valley and Wessex	13,482	1,430	1,261	1,295	1,336	1,202	1,098	1,288	933	935	895	866	943
West London, North London, Surrey and Sussex	13,466	1,221	1,092	1,191	1,312	1,195	1,082	1,253	1,217	1,319	881	849	854
West Midlands	14,105	1,352	1,160	1,194	1,369	1,160	1,041	1,265	1,172	1,248	983	1,043	1,118
West Yorks, South Yorks and Humber	15,966	1,448	1,260	1,329	1,484	1,302	1,301	1,453	1,402	1,421	1,398	1,063	1,105

Episodes - Quarterly

National and regional comparison of episode totals in current year to most recent pre-2020 year.

England:

Radiotherapy Network:

Episode Trends - current and pre 2020

Episodes in the current and pre 2020 year: England

Episodes in the current and pre 2020 year: Radiotherapy Network

Episodes in the last 5 years

Episodes in the last 5 years: England

Episodes in the last 5 years: Radiotherapy Network

Radical Episodes

Radical episodes table

Radiotherapy Network		07/2024	08/2024	09/2024	10/2024	11/2024	12/2024	01/2025	02/2025	03/2025	04/2025	05/2025	06/2025	Total
East Midlands	Radical Episodes	668	594	609	685	633	545	702	611	499	513	456	449	6,964
	All Episodes	929	833	889	915	908	784	932	885	694	720	710	640	9,839
	% Radical	72%	71%	69%	75%	70%	70%	75%	69%	72%	71%	64%	70%	71%
East of England	Radical Episodes	799	736	737	835	732	644	822	722	767	556	536	562	8,448
	All Episodes	1,164	1,105	1,068	1,175	1,075	992	1,159	1,066	1,132	828	819	841	12,424
	% Radical	69%	67%	69%	71%	68%	65%	71%	68%	68%	67%	65%	67%	68%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Radical Episodes	1,415	1,311	1,308	1,352	1,364	1,196	1,370	1,210	1,299	1,292	1,179	1,176	15,472
	All Episodes	1,937	1,803	1,765	1,833	1,844	1,658	1,849	1,645	1,745	1,751	1,636	1,661	21,127
	% Radical	73%	73%	74%	74%	74%	72%	74%	74%	74%	74%	72%	71%	73%
North Central and North East London	Radical Episodes	978	829	898	952	866	753	873	787	824	836	786	398	9,780
	All Episodes	1,345	1,114	1,204	1,303	1,177	1,028	1,210	1,072	1,171	1,141	1,118	576	13,459
	% Radical	73%	74%	75%	73%	74%	73%	72%	73%	70%	73%	70%	69%	73%
North East and Cumbria	Radical Episodes	591	517	539	594	533	537	622	586	677	577	550	676	6,999
	All Episodes	860	802	799	857	803	818	891	856	945	859	815	930	10,235
	% Radical	69%	64%	67%	69%	66%	66%	70%	68%	72%	67%	67%	73%	68%
Peninsula, Somerset, Avon and Gloucestershire	Radical Episodes	936	818	816	907	807	754	930	791	818	856	798	843	10,074
	All Episodes	1,382	1,221	1,244	1,391	1,190	1,208	1,370	1,245	1,220	1,315	1,237	1,297	15,320
	% Radical	68%	67%	66%	65%	68%	62%	68%	64%	67%	65%	65%	65%	66%
South East London, Kent and Medway	Radical Episodes	538	485	501	546	491	448	547	462	498	463	474	491	5,944
	All Episodes	806	734	704	799	757	700	794	687	747	695	705	765	8,893
	% Radical	67%	66%	71%	68%	65%	64%	69%	67%	67%	67%	67%	64%	67%
Thames Valley and Wessex	Radical Episodes	939	887	882	913	813	745	850	619	594	586	546	601	8,975
	All Episodes	1,430	1,261	1,295	1,336	1,202	1,098	1,288	933	935	895	866	943	13,482
	% Radical	66%	70%	68%	68%	68%	68%	66%	66%	64%	65%	63%	64%	67%
West London, North London, Surrey and Sussex	Radical Episodes	850	776	854	923	812	703	889	841	934	579	534	578	9,273
	All Episodes	1,221	1,092	1,191	1,312	1,195	1,082	1,253	1,217	1,319	881	849	854	13,466
	% Radical	70%	71%	72%	70%	68%	65%	71%	69%	71%	66%	63%	68%	69%
West Midlands	Radical Episodes	932	781	849	945	766	681	903	784	866	659	697	769	9,632
	All Episodes	1,352	1,160	1,194	1,369	1,160	1,041	1,265	1,172	1,248	983	1,043	1,118	14,105
	% Radical	69%	67%	71%	69%	66%	65%	71%	67%	69%	67%	67%	69%	68%
West Yorks, South Yorks and Humber	Radical Episodes	1,038	912	960	1,089	937	970	1,091	1,019	1,061	1,060	790	855	11,782
	All Episodes	1,448	1,260	1,329	1,484	1,302	1,301	1,453	1,402	1,421	1,398	1,063	1,105	15,966
	% Radical	72%	72%	72%	73%	72%	75%	75%	73%	75%	76%	74%	77%	74%

Country		07/2024	08/2024	09/2024	10/2024	11/2024	12/2024	01/2025	02/2025	03/2025	04/2025	05/2025	06/2025	Total
England	Radical Episodes	9,684	8,646	8,953	9,741	8,754	7,976	9,599	8,432	8,837	7,977	7,346	7,398	103,343
	All Episodes	13,874	12,385	12,682	13,774	12,613	11,710	13,464	12,180	12,577	11,466	10,861	10,730	148,316
	% Radical	70%	70%	71%	71%	69%	68%	71%	69%	70%	70%	68%	69%	70%

Radical episodes - Quarters

Percentage of episodes that were radical by financial quarter, comparing current and pre 2020 years

England:

Radiotherapy Network:

Radical episode (%) trends - current and pre 2020

Radical episodes (%) in the current and pre 2020 year: England

Radical episodes (%) in the current and pre 2020 year: Radiotherapy Network

Radical episodes (%) in the last 5 years

Radical episodes (%) in the last 5 years: England

Radical episodes (%) in the last 5 years: Radiotherapy Network

Attendances

Attendances table

Radiotherapy Network	Total	07/2024	08/2024	09/2024	10/2024	11/2024	12/2024	01/2025	02/2025	03/2025	04/2025	05/2025	06/2025
Total	1,686,174	156,792	144,929	142,158	158,789	147,853	139,620	149,464	135,742	140,476	130,261	126,278	113,812
East Midlands	123,462	11,520	10,236	10,102	11,711	11,509	10,959	12,430	11,050	8,963	8,510	9,088	7,384
East of England	142,856	13,617	12,838	12,403	13,592	13,360	11,917	12,669	11,943	12,512	9,653	9,304	9,048
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	243,802	22,415	21,140	19,827	22,485	20,978	19,625	21,026	19,089	19,565	20,197	19,613	17,842
North Central and North East London	160,805	15,511	13,726	14,046	15,635	14,942	13,595	14,025	12,529	13,391	13,485	14,274	5,646
North East and Cumbria	106,225	9,268	7,936	8,018	8,827	7,968	8,694	9,396	9,034	9,562	9,300	8,799	9,423
Peninsula, Somerset, Avon and Gloucestershire	155,132	14,054	12,704	12,768	13,915	12,899	12,178	12,775	12,309	12,885	13,089	12,987	12,569
South East London, Kent and Medway	107,627	9,928	9,107	8,643	10,056	9,488	8,590	9,467	8,378	8,319	8,592	8,547	8,512
Thames Valley and Wessex	148,956	15,246	15,055	14,718	15,210	13,873	12,643	14,018	9,573	9,926	9,792	9,511	9,391
West London, North London, Surrey and Sussex	152,926	13,835	12,748	13,172	15,521	13,698	13,194	13,624	13,084	14,630	10,033	9,815	9,572
West Midlands	171,042	15,988	14,697	14,610	16,730	14,681	13,275	14,526	13,941	15,160	12,290	12,428	12,716
West Yorks, South Yorks and Humber	173,341	15,410	14,742	13,851	15,107	14,457	14,950	15,508	14,812	15,563	15,320	11,912	11,709

Attendances - Quarterly

National and regional comparison of attendance totals in current year to most recent pre-2020 year.

England:

Radiotherapy Network:

Attendance Trends - current and pre 2020

Attendances in the current and pre 2020 year: England

Attendances in the current and pre 2020 year: Radiotherapy Network

Attendances in the last 5 years

Attendances in the last 5 years: England

Attendances in the last 5 years: Radiotherapy Network

Service Attendances - RAD20

Service Attendances

Machine Attendances (RAD20) - April 2024 to March 2025

Count by machine type

Attendance by machine type and Radiotherapy Network:

Percentage LINAC

Percentage of attendances LINAC
Radiotherapy Network	% LINAC
East Midlands	99%
East of England	97%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	98%
North Central and North East London	98%
North East and Cumbria	99%
Peninsula, Somerset, Avon and Gloucestershire	98%
South East London, Kent and Medway	98%
Thames Valley and Wessex	99%
West London, North London, Surrey and Sussex	98%
West Midlands	98%
West Yorks, South Yorks and Humber	98%

RAD20 Over Time

Machine Attendances (RAD20) - LINAC Attendances

England:

Radiotherapy Network:

RAD20 National Annual Average

RAD20: Departmental average number of attendances per LINAC by financial year.

Financial years only: April-March

National Annual Average

Averages by Radiotherapy Network

Interpretation guidance: Higher is better
Reference Line: National annual average

Quality Dashboard

Specification

Specification for this version:

Unless otherwise stated

Proportion (%) = Sum(Numerator)/Sum(Denominator)

Working days=Sum(Numerator - Number of days waiting)/Sum(Denominator - number of episodes starting in that month) - (RAD16 only)

In the national overview RAD13A/B/C is the the total episodes for the whole country for each year. In the breakdown by radiotherapy network the figure shown is simply the sum of the numerator for the year for that network.

RAD19 is not included in this summary as its maximum end date is 2 months less than the metrics displayed here due to necessary followups.

Quality Dashboard Dates:

Annual Metric Dates
Time period	Start date	End date
Current Year	July 2024	June 2025
Previous Year	July 2023	June 2024

Quarterly Metric Dates
Quarter	Month
Curr Qtr	June 2025
	May 2025
	April 2025
Prev Qtr 1	March 2025
	February 2025
	January 2025
Prev Qtr 2	December 2024
	November 2024
	October 2024
Prev Qtr 3	September 2024
	August 2024
	July 2024

Quality Dashboard Overview

Quality Dashboard Overview: July 2024 to June 2025

Yearly Metrics

National Overview: Yearly metrics

Previous year: July 2023 to June 2024, Current year: July 2024 to June 2025

Benchmarks: RAD13: 25 episodes higher is better, RAD15: 80% higher is better

Underlying Data - Overview

Quarterly Metrics - RAD12, RAD14, RAD17, RAD18
Metric		Prev Qtr 3	Prev Qtr 2	Prev Qtr 1	Curr Qtr
RAD12a	Proportion	31%	31%	33%	29%
	Numerator	7,560	7,293	7,822	5,978
	Denominator	24,423	23,731	24,046	20,461
RAD12b	Proportion	8%	9%	9%	9%
	Numerator	879	949	952	878
	Denominator	11,039	10,966	10,627	9,723
RAD14	Proportion	60%	60%	59%	60%
	Numerator	14,629	14,156	14,199	12,207
	Denominator	24,455	23,744	24,074	20,488
RAD17	Proportion	100%	100%	100%	99%
	Numerator	8,738	8,514	8,808	7,423
	Denominator	8,753	8,527	8,841	7,463
RAD18	Proportion	72%	70%	70%	69%
	Numerator	3,035	2,969	2,876	2,487
	Denominator	4,235	4,222	4,093	3,594

Quarterly Metric RAD16 - Average days waiting
Metric		Prev Qtr 3	Prev Qtr 2	Prev Qtr 1	Curr Qtr
RAD16	Working days	33	34	30	36
	Numerator	170,091	167,521	140,449	148,788
	Denominator	5,105	4,881	4,683	4,123

Annual Metric RAD15 - Proportion %
Metric		Previous Year	Current Year
RAD15a	Proportion	93%	94%
	Numerator	7,533	7,759
	Denominator	8,076	8,232
RAD15b	Proportion	96%	97%
	Numerator	22,191	22,978
	Denominator	23,079	23,706
RAD15c	Proportion	97%	97%
	Numerator	6,595	6,565
	Denominator	6,803	6,755

Annual Metric RAD13 - Total Numerator
Metric		Previous Year	Current Year
RAD13a	Numerator	8,076	8,232
RAD13b	Numerator	3,564	3,895
RAD13c	Numerator	6,803	6,755
RAD13d	Numerator	1,039	1,069

Quality Dashboard Network Overview

RAD12

RAD12 - Number of patients waiting longer than 31 days from decision to treat date to date of first treatment - Radical Treatment (A), Palliative Treatment (B), BM: 20% Lower better

RAD13

RAD13 - Number of episodes of radical treatment by tumour site - Lung - inc. SABR (A), Lung - SABR Only (B), Head & Neck (C), Cervix (D), BM: 25 Episodes

RAD14

RAD14: Proportion of all Radiotherapy Radical episodes receiving Inverse Planned IMRT (excluding breast). BM: 24% Higher better

RAD15

RAD15 - Proportion of radical patients treated using image guidance. Lung (A), Prostate (B), Head & Neck (C), BM: 80% Higher is better

RAD16

RAD16 - Mean waiting time (in days) from date of referral to radiotherapy department to the date of treatment commencing for Category 1 patients BM: 31 days lower is better

RAD17

Radiotherapy Network:

Percentage

Radical Episodes by Speciality (percentage) - Urology

England:

Radiotherapy Network:

Dose and Fractions

Unless otherwise stated the following data is for radical episodes only.

Breast

Dose fractionation schedules

Dose and Fractions - BREAST (July 2024 to June 2025)

Percentage of breast episodes by Radiotherapy Network and dose fractionation schedules.

Number of breast episodes by Radiotherapy Network and dose fractionation schedules.

Table

Table: number and percentage of breast episodes by Radiotherapy Network and dose fractionation schedules.

Radiotherapy Network		Total	26 Gy in 5 fractions	40 Gy in 15 fractions	48 Gy in 15 fractions	other
Total	Episodes	33,107	22,534	8,551	775	1,247
Total	Percentage	100%	68%	26%	2%	4%
East Midlands	Episodes	2,372	1,610	608	102	52
East Midlands	Percentage	7%	5%	2%	0%	0%
East of England	Episodes	2,880	1,914	599	202	165
East of England	Percentage	9%	6%	2%	1%	0%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Episodes	4,523	2,741	1,234	247	301
	Percentage	14%	8%	4%	1%	1%
North Central and North East London	Episodes	3,090	2,109	813	23	145
North Central and North East London	Percentage	9%	6%	2%	0%	0%
North East and Cumbria	Episodes	2,133	1,615	480	25	13
North East and Cumbria	Percentage	6%	5%	1%	0%	0%
Peninsula, Somerset, Avon and Gloucestershire	Episodes	3,371	2,404	793	4	170
Peninsula, Somerset, Avon and Gloucestershire	Percentage	10%	7%	2%	0%	1%
South East London, Kent and Medway	Episodes	2,065	1,458	566	1	40
South East London, Kent and Medway	Percentage	6%	4%	2%	0%	0%
Thames Valley and Wessex	Episodes	3,053	2,282	649	55	67
Thames Valley and Wessex	Percentage	9%	7%	2%	0%	0%
West London, North London, Surrey and Sussex	Episodes	2,981	2,023	782	66	110
West London, North London, Surrey and Sussex	Percentage	9%	6%	2%	0%	0%
West Midlands	Episodes	3,256	2,059	1,108	26	63
West Midlands	Percentage	10%	6%	3%	0%	0%
West Yorks, South Yorks and Humber	Episodes	3,383	2,319	919	24	121
West Yorks, South Yorks and Humber	Percentage	10%	7%	3%	0%	0%

RCR Schedules

Count

Number of breast episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Percentage

Percentage of breast episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Fraction Categories

Number of breast episodes by Radiotherapy Network, financial quarter and fractionation category

Dose fractionation schedules

Dose and Fractions - LUNG (July 2024 to June 2025)

Percentage of lung episodes by Radiotherapy Network and dose fractionation schedules.

Number of lung episodes by Radiotherapy Network and dose fractionation schedules.

Table

Table: number and percentage of lung episodes by Radiotherapy Network and dose fractionation schedules.

Radiotherapy Network		Total	30-60 Gy in 1-8 fractions	40-55 Gy in 15-20 fractions	45-66 Gy in 25-33 fractions	54 Gy in 36 fractions	other
Total	Episodes	8,139	3,290	2,028	1,156	23	1,642
Total	Percentage	100%	40%	25%	14%	0%	20%
East Midlands	Episodes	412	115	100	106	0	91
East Midlands	Percentage	5%	1%	1%	1%	0%	1%
East of England	Episodes	420	186	150	47	0	37
East of England	Percentage	5%	2%	2%	1%	0%	0%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Episodes	1,737	404	488	142	1	702
	Percentage	21%	5%	6%	2%	0%	9%
North Central and North East London	Episodes	592	204	100	120	0	168
North Central and North East London	Percentage	7%	3%	1%	1%	0%	2%
North East and Cumbria	Episodes	919	447	261	83	0	128
North East and Cumbria	Percentage	11%	5%	3%	1%	0%	2%
Peninsula, Somerset, Avon and Gloucestershire	Episodes	771	370	142	112	3	144
Peninsula, Somerset, Avon and Gloucestershire	Percentage	9%	5%	2%	1%	0%	2%
South East London, Kent and Medway	Episodes	410	146	111	86	0	67
South East London, Kent and Medway	Percentage	5%	2%	1%	1%	0%	1%
Thames Valley and Wessex	Episodes	718	333	123	148	1	113
Thames Valley and Wessex	Percentage	9%	4%	2%	2%	0%	1%
West London, North London, Surrey and Sussex	Episodes	438	189	117	92	0	40
West London, North London, Surrey and Sussex	Percentage	5%	2%	1%	1%	0%	0%
West Midlands	Episodes	615	305	188	65	0	57
West Midlands	Percentage	8%	4%	2%	1%	0%	1%
West Yorks, South Yorks and Humber	Episodes	1,107	591	248	155	18	95
West Yorks, South Yorks and Humber	Percentage	14%	7%	3%	2%	0%	1%

Radiotherapy Network:

Oesophagus

Dose fractionation schedules

Dose and Fractions - OESOPHAGUS (July 2024 to June 2025)

Percentage of oesophagus episodes by Radiotherapy Network and dose fractionation schedules.

Number of oesophagus episodes by Radiotherapy Network and dose fractionation schedules.

Table

Table: number and percentage of oesphagus episodes by Radiotherapy Network and dose fractionation schedules.

Radiotherapy Network		Total	40-55 Gy in 15-20 fractions	41.5-45 Gy in 23-28 fractions	50-66 Gy in 25-30 fractions	other
Total	Episodes	1,333	238	146	815	134
Total	Percentage	100%	18%	11%	61%	10%
East Midlands	Episodes	73	11	18	34	10
East Midlands	Percentage	5%	1%	1%	3%	1%
East of England	Episodes	113	29	18	59	7
East of England	Percentage	8%	2%	1%	4%	1%
Greater Manchester, Cheshire, Mersey, Lancashire and South Cumbria	Episodes	180	31	4	127	18
	Percentage	14%	2%	0%	10%	1%
North Central and North East London	Episodes	104	20	13	58	13
North Central and North East London	Percentage	8%	2%	1%	4%	1%
North East and Cumbria	Episodes	123	44	12	63	4
North East and Cumbria	Percentage	9%	3%	1%	5%	0%
Peninsula, Somerset, Avon and Gloucestershire	Episodes	134	10	14	90	20
Peninsula, Somerset, Avon and Gloucestershire	Percentage	10%	1%	1%	7%	2%
South East London, Kent and Medway	Episodes	91	12	9	57	13
South East London, Kent and Medway	Percentage	7%	1%	1%	4%	1%
Thames Valley and Wessex	Episodes	119	7	16	83	13
Thames Valley and Wessex	Percentage	9%	1%	1%	6%	1%
West London, North London, Surrey and Sussex	Episodes	113	3	23	78	9
West London, North London, Surrey and Sussex	Percentage	8%	0%	2%	6%	1%
West Midlands	Episodes	137	31	8	87	11
West Midlands	Percentage	10%	2%	1%	7%	1%
West Yorks, South Yorks and Humber	Episodes	146	40	11	79	16
West Yorks, South Yorks and Humber	Percentage	11%	3%	1%	6%	1%

RCR Schedules

Count

Number of oesophagus episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Percentage

Percentage of oesophagus episodes by Radiotherapy Network, financial quarter and schedule group.

England:

Radiotherapy Network:

Fraction Categories

Number of oesophagus episodes by Radiotherapy Network, financial quarter and fractionation category

Episodes and Attendances

Groupings are as below:

Brain and CNS: Brain (C71), Meninges (C70), Other CNS (C47, C72, D32-D33, D35, D42-D44), Pituitary (D352)

Gynae: Cervix (C53), Other gynae (C56-C57), Uterus (C54-C55), Vagina (C52), Vulva (C51)

Lower GI: Anal (C21), Other lower GI (C17-C18, C26), Rectal (C20), Rectosigmoid (C19)

Upper GI: HepatoPancreatoBiliary (C22-C25), Oesophagus (C15), Stomach (C16)

Urology: Bladder and ureter (C66-C67), Other urology (C63-C65, C68), Penis (C60), Prostate (C61), Testis (C62)

Quality Dashboard

The details of what is required for each submission can be found here:

Specialised Services Quality Dashboards

The metrics show what submissions are required for each indicator and whether the data is provider submitted or externally provided (for example from NDRS).

Dose and Fractions

Groupings are as below:

Breast (C50)

Head and neck (C00-C14, C30-C32)

Lung (C33, C34, excluding where Treatment Region = ‘O’ Prophylactic (to non primary site))

Prostate (C61; men only)

Oesophagus (C15)